RP Management’s Epizyme, Inc EPZM Stock Holding History

RP Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-31,841,394	Closed	-$46.8M	–	5
2022 Q2	$46.8M	Buy	31,841,394 +8,060	+0%	+$5.92K	18.49%	2
2022 Q1	$47.8M	Buy	31,833,334 +22,666,667	+247%	+$37M	19.42%	3
2021 Q4	$22.9M	Hold	9,166,667	–	–	9.59%	3
2021 Q3	$46.9M	Hold	9,166,667	–	–	21.9%	2
2021 Q2	$76.2M	Hold	9,166,667	–	–	37.14%	2
2021 Q1	$79.8M	Hold	9,166,667	–	–	29.97%	2
2020 Q4	$99.5M	Hold	9,166,667	–	–	30.54%	2
2020 Q3	$109M	Hold	9,166,667	–	–	16.39%	3
2020 Q2	$147M	Hold	9,166,667	–	–	28.46%	3
2020 Q1	$142M	Buy	9,166,667 +2,500,000	+37%	+$53.7M	44.14%	1
2019 Q4	$164M	Buy	+6,666,667	New	+$99M	37.08%	1

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

RP Management's EPZM Position: Q3 2022 in Review

RP Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 31,841,394 shares — an estimated $46.8M sold.

RP Management first reported a position in EPZM in Q4 2019 and held it in 11 quarters. The position peaked at $164M in Q4 2019. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

RP Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
RP Management sold 31,841,394 Epizyme, Inc shares in Q3 2022, an estimated $46.8M.
RP Management first reported a position in Epizyme, Inc in Q4 2019 and held it in 11 quarters.
RP Management's Epizyme, Inc position peaked at $164M in Q4 2019.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on RP Management's 13F filing for Q3 2022, filed 14 Nov 2022.